Argonne to Explore Novel Ways to Fight Cancer and Transform Vaccine Discovery with Over $21 Million From ARPA-H

Argonne has received up to $21 million from ARPA-H to use AI and supercomputing in two projects: one targeting hard-to-treat tumors, and another aiming to create vaccines for multiple viral threats, including cancer and pandemics. 

Read More